Bayesian Inductive Logic Programming

Total Page:16

File Type:pdf, Size:1020Kb

Bayesian Inductive Logic Programming Bayesian Inductive Logic Programming Stephen Muggleton Oxford University Computing Laboratory Wolfson Building, Parks Road Oxford, OX1 3QD. Abstract 1 INTRODUCTION Inductive Logic Progrdng (ILP) involves the This paper is written for two separate audiences: 1) a Ma- construction of first-order definite clause theories chine Learning audience, interested in implementations and from examples and background knowledge, Un- applications and 2) a Computational Learning Theory audl- like both traditional Machine Learning and Com- ence interested in models and results in learnability. The putational Learning Theory, ILP is based on lock- paper should thus be taken as two loosely connected papers step development of Theory, Implementations and with a common theme involving the use of distributional Applications. ILP systems have successful appli- information in Inductive Logic Programming (ILP). cations in the learning of structure-activity rules In the last few years ILP [23, 24,20, 31] has developed from for drug design, semantic grammars rules, finite a theoretical backwater to a rapidly growing area in Machine element mesh design rules and rules for prediction Learning. This is in part due to the fact that pure logic of protein structure and mutagenic molecules. The programs provide Machine Learning with a representation strong applications in ILP can be contrasted with relatively weak PAC-learning results (even highly- which is general purpose (Turing-computable), and has a restricted forms of logic programs are known to simple, and rigorously defined, semantics. In addition, logic programs tend to be easy to comprehend as hypotheses in be prediction-hard). It has been recently argued scientific domains. that the mismatch is due to distributional assump- tions made in application domains. These assump- ILP is based on interaction between Theory, Implementations tions can be modelled as a Bayesiau prior prob- and Applications. The author has argued [25] that the devel- ability representing subjective degrees of belief. opment of a formal semantics of ILP (see Section 2) allows Other authors have argued for the use of Bayesian the direct derivation of ILP algorithms. Such derivational prior distributions for reasons different to those techniques have been at the centre of specific-to-general here, though this has not lead to a new model ILP techniques such as Plotkin’s least general generalisation of polynomial-time learnability. Incorporation of [37, 36], Muggleton and Buntine’s inverse resolution [27, 23] Bayesian prior distributions over time-bounded hy- and Idestam-Almquist’s inverse implication [ 15]. TWO con- potheses in PAC leads to a new model called U- tending semantics of ILP have been developed [31]. These Learnability. It is argued that U-learnability is are the so-called ‘open-world’ semantics [31 ] and ‘closed- more appropriate than PAC for Universal (Tur- world’ semantics [13]. ing computable) languages. Time-bounded logic programs have been shown to be polynomially A number of efficient ILP systems have been developed, in- U-learnable under certain distributions. The use cluding FOIL [38], Golem [28], LINUS [21], CLAUDIEN of time-bounded hypotheses enforces decidability [39] and Progol [26]. The use of a relational logic formalism and allows a unified characterisation of speed-up has allowed successful application of ILP systems in a num- learning and inductive learning. U-learnability has ber of domains in which the concepts to be learned cannot as special cases PAC and Natarajan’s model of easily be described in an attribute-value, propositional-level, speed-up learning. language. These applications (see Section 3) include struc- ture activity prediction for drug design [19, 44, 43], protein Permission to copy without fee all or part of this material is secondary-structure prediction [29], finite-element mesh de- granted provided that the copies are not made or distributed for sign [9] and learning semantic grammars [45]. direct commercial advantage, the ACM copyright notice and the title of the publication and its date appear, and notice is given A variety of positive and negative PAC-learnability results ex- that copying is by permission of the Association of Computing Machinery. To copy otherwise, or to republish, requires a fee ist for subsets of definite clause logic [11, 34, 10, 18, 7, 40]. and/or specific permission. However, in contrast to experimentally demonstrated abili- COLT 94- 7/94 New Brunswick, N..J. USA ties of ILP systems in applications, the positive PAC results @ 1994 ACM 0-89791-655-7/94/0007..$3.50 are rather weak, and even highly restricted forms of logic 3 programs have been shown to be prediction hard [7]. Like where H Q cd, H 1= B and n is a a natural number. Hn many other results in PAC-learning, positive results are only is said to hold for examples E, or holds(Hn, E), when both achieved for ILP by setting language parameters to constant the following are truel. values (eg. k-clauses and l-literals). This provides ‘hard’ boundaries to the hypothesis space, which often reduces Sufficiency: H h. E+ the representation to a propositional level. An alternative Satisfiability: H A E- tjn ❑ model, U-learnability [30], is better suited to Universal (Tur- ing computable) representations, such as logic programs. U- The prior probability, p(Hn), of an hypothesis is defined by learnability provides a ‘soft’ boundary to hypothesis spaces in a given distribution D. According to Bayes’ theorem, the the form of a prior probability distribution over the complete posterior probability is representation (eg. time-bounded logic programs). Other authors have argued for the use of Bayesian prior distribu- p(EIHn).p(Hn) tions for reasons different to those here, though this has not P(~nl~)= p(E) lead to a new model of polynomial-time learnability. U- where p(E[Hn) is 1 when holds(Hn, E) and O otherwise Iearnability allows standard distributional assumptions, such and as Occam’s razor, to be used in a natural manner, without p(E) = ~ p(H:) parameter settings. Although Occam algorithms have been studied in PAC-learning [3], this has not led to algorithms holds (H& ,E) capable of learning in universal representations, as it has in Well known strategies for making use of distributional infor- Inductive Logic Programming. In the early 1980’s a distribu- mation include a) maximisation of posterior probability b) tion assumption very different to Occam’s razor was implic- class prediction based on posterior weighted sum of predic- itly implemented by Arbab, Michie [1] and Bratko [4] in an tions of all hypotheses (Bayes optimal strategy) c) randomly algorithm for constructing decision trees. The algorithm con- sampling an hypothesis from the posterior probability (Gibbs structs a decision list (linear decision tree) where one exists algorithm). The sample complexities of strategies b) and c) and otherwise returns the most linear decision tree which can are analysed in [12]. be constructed from the data. This distributional assumption Although no existing ILP system takes an hypothesis distri- is based on the fact that decision lists are generally easier to bution D as an input parameter, such distributions are implicit comprehend than arbitrary decision trees. Other interesting in FOIL’s [38] information gain measure and Golem’s [32] kinds of distributions along these lines can be imagined; as- compression measure. Additionally, search strategies such signing higher prior probabilities to grammars that are regular as general-to-specific or specific-to-general, use an implicit or almost so, logic programs that are deterministic or almost prior distribution which favours more general hypotheses or, so and logic programs that run in linear time or almost so. conversely, more specific ones. One can imagine very different kinds of prior distributions on hypotheses. For example, when learning concepts which Bayesian approaches to Machine Learning have been dis- mimic human performance in skill tasks [41] predictive ac- cussed previously in the literature. For instance, Buntine curacy is dependent on hypotheses being evaluable in time [6] develops a Bayesian framework for learning, which he similar to that of human reaction, and so such hypotheses applies to the problem of learning class probability trees. should be preferred a priori. Also Haussler et al. [12] analyse the sample complexity of two Bayesian algorithms. This analysis focuses on average This paper is organised as follows. Section 2 gives a formal case, rather than worst case, accuracy. On the other hand definition of ILP in terms of Bayesian inference. Section 3 U-learnability uses average case time complexity and worst provides an overview of ILP applications in molecular bi- case accuracy. Also unlike U-learnability (Section 4) neither ology and discusses some of the distributional assumptions used in these applications. Section 4 defines U-learnability Buntine nor Haussler et al, develop a new learning model which allows significantly larger polynomially-learnable rep- and describes some general results on U-learnable distribu- resentations, such as logic programs. The applications in the tions. following section show that ILP systems are effective at learn- ing logic programs in significant real-world domains. This 2 BAYES’ ILP DEFINITIONS is consistent with the fact that time-bounded logic programs are U-learnable under certain distributions (see Section 4). Familiarity with standard definitions from Logic Program- ming [22, 14] is assumed in the following. A Bayesian ver- 3 APPLICATIONS IN MOLECULAR sion of the usual (open world semantics) setting for ILP is as BIOLOGY follows. Suppose T, 7 and V are sets of predicate symbols, function symbols and variables and cd and Ch are the classes ILP applications in Molecular Biology extend a long tradi- of definite and Horn clauses constructed from T, 7 and V. tion in approaches to scientific discovery that was initiated by The symbol En denotes SLDNF derivation bounded by n res- Meta-Dendral’s [5] application in mass spectrometry.
Recommended publications
  • Predicting and Characterising Protein-Protein Complexes
    Predicting and Characterising Protein-Protein Complexes Iain Hervé Moal June 2011 Biomolecular Modelling Laboratory, Cancer Research UK London Research Institute and Department of Biochemistry and Molecular Biology, University College London A thesis submitted in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Biochemistry at the University College London. 2 I, Iain Hervé Moal, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. Abstract Macromolecular interactions play a key role in all life processes. The con- struction and annotation of protein interaction networks is pivotal for the understanding of these processes, and how their perturbation leads to dis- ease. However the extent of the human interactome and the limitations of the experimental techniques which can be brought to bear upon it necessit- ate theoretical approaches. Presented here are computational investigations into the interactions between biological macromolecules, focusing on the structural prediction of interactions, docking, and their kinetic and thermo- dynamic characterisation via empirical functions. Firstly, the use of normal modes in docking is investigated. Vibrational analysis of proteins are shown to indicate the motions which proteins are intrinsically disposed to under- take, and the use of this information to model flexible deformations upon protein-protein binding is evaluated. Subsequently SwarmDock, a docking algorithm which models flexibility as a linear combination of normal modes, is presented and benchmarked on a wide variety of test cases. This algorithm utilises state of the art energy functions and metaheuristics to navigate the free energy landscape.
    [Show full text]
  • Functional Effects Detailed Research Plan
    GeCIP Detailed Research Plan Form Background The Genomics England Clinical Interpretation Partnership (GeCIP) brings together researchers, clinicians and trainees from both academia and the NHS to analyse, refine and make new discoveries from the data from the 100,000 Genomes Project. The aims of the partnerships are: 1. To optimise: • clinical data and sample collection • clinical reporting • data validation and interpretation. 2. To improve understanding of the implications of genomic findings and improve the accuracy and reliability of information fed back to patients. To add to knowledge of the genetic basis of disease. 3. To provide a sustainable thriving training environment. The initial wave of GeCIP domains was announced in June 2015 following a first round of applications in January 2015. On the 18th June 2015 we invited the inaugurated GeCIP domains to develop more detailed research plans working closely with Genomics England. These will be used to ensure that the plans are complimentary and add real value across the GeCIP portfolio and address the aims and objectives of the 100,000 Genomes Project. They will be shared with the MRC, Wellcome Trust, NIHR and Cancer Research UK as existing members of the GeCIP Board to give advance warning and manage funding requests to maximise the funds available to each domain. However, formal applications will then be required to be submitted to individual funders. They will allow Genomics England to plan shared core analyses and the required research and computing infrastructure to support the proposed research. They will also form the basis of assessment by the Project’s Access Review Committee, to permit access to data.
    [Show full text]
  • Development of Novel Strategies for Template-Based Protein Structure Prediction
    Imperial College London Department of Life Sciences PhD Thesis Development of novel strategies for template-based protein structure prediction Stefans Mezulis supervised by Prof. Michael Sternberg Prof. William Knottenbelt September 2016 Abstract The most successful methods for predicting the structure of a protein from its sequence rely on identifying homologous sequences with a known struc- ture and building a model from these structures. A key component of these homology modelling pipelines is a model combination method, responsible for combining homologous structures into a coherent whole. Presented in this thesis is poing2, a model combination method using physics-, knowledge- and template-based constraints to assemble proteins us- ing information from known structures. By combining intrinsic bond length, angle and torsional constraints with long- and short-range information ex- tracted from template structures, poing2 assembles simplified protein models using molecular dynamics algorithms. Compared to the widely-used model combination tool MODELLER, poing2 is able to assemble models of ap- proximately equal quality. When supplied only with poor quality templates or templates that do not cover the majority of the query sequence, poing2 significantly outperforms MODELLER. Additionally presented in this work is PhyreStorm, a tool for quickly and accurately aligning the three-dimensional structure of a query protein with the Protein Data Bank (PDB). The PhyreStorm web server provides comprehensive, current and rapid structural comparisons to the protein data bank, providing researchers with another tool from which a range of biological insights may be drawn. By partitioning the PDB into clusters of similar structures and performing an initial alignment to the representatives of each cluster, PhyreStorm is able to quickly determine which structures should be excluded from the alignment.
    [Show full text]
  • Centre for Bioinformatics Imperial College London
    Centre for Bioinformatics Imperial College London Inaugural Report January 2003 Centre Director: Prof Michael Sternberg www.imperial.ac.uk/bioinformatics [email protected] Support Service Head: Dr Sarah Butcher www.codon.bioinformatics.ic.ac.uk [email protected] Centre for Bioinformatics - Imperial College London - Inaugural Report - January 2003 1 Contents Summary..................................................................................................................... 3 1. Background and Objectives .................................................................................... 4 1.1 Background ....................................................................................................... 4 1.2 Objectives of the Centre for Bioinformatics ....................................................... 4 1.3 Objectives of the Bioinformatics Support Service.............................................. 5 1.4 Historical Notes ................................................................................................. 5 2. Management ........................................................................................................... 6 3. Biographies of the Team......................................................................................... 7 4. Bioinformatics Research at Imperial ....................................................................... 8 4.1 Affiliates of the Centre ....................................................................................... 8 4.2 Research Grants
    [Show full text]
  • Centre for Bioinformatics Imperial College London Second Report 31
    Centre for Bioinformatics Imperial College London Second Report 31 May 2004 Centre Director: Prof Michael Sternberg www.imperial.ac.uk/bioinformatics [email protected] Support Service Head: Dr Sarah Butcher www.codon.bioinformatics.ic.ac.uk [email protected] Centre for Bioinformatics - Imperial College London - Second Report - May 2004 1 Contents Summary..................................................................................................................... 3 1. Background and Objectives .................................................................................. 4 1.1 Objectives of the Report........................................................................................ 4 1.2 Background........................................................................................................... 4 1.3 Objectives of the Centre for Bioinformatics........................................................... 5 1.4 Objectives of the Bioinformatics Support Service ................................................. 5 2. Management ......................................................................................................... 6 3. Biographies of the Team....................................................................................... 7 4. Bioinformatics Research at Imperial ..................................................................... 8 4.1 Affiliates of the Centre........................................................................................... 8 4.2 Research..............................................................................................................
    [Show full text]
  • Spinout Equinox Pharma Speeds up and Reduces the Cost of Drug Discovery
    Spinout Equinox Pharma speeds up and reduces the cost of drug discovery pinout Equinox Pharma1 provides a service to the pharma and biopharma industries that helps in the development of new drugs. The company, established by researchers from Imperial College London in IMPACT SUMMARY 2008, is using its own proprietary software to help speed up and reduce the cost of discovery processes. S Spinout Equinox Pharma provides services to the agri- tech and pharmaceuticals industries to accelerate the Equinox is based on BBSRC-funded collaborative research The technology also has applications in the agrochemical discovery of molecules that could form the basis of new conducted by Professors Stephen Muggleton2, Royal sector, and is being used by global agri-tech company products such as drugs or herbicides. Academy Chair in Machine Learning, Mike Sternberg3, Chair Syngenta. The company arose from BBSRC bioinformatics and of Structural Bioinformatics, and Paul Freemont4, Chair of structural biology research at Imperial College London. Protein Crystallography, at Imperial College London. “The power of a logic-based approach is that it can Technology commercialisation company NetScientific propose chemically-novel molecules that can have Ltd has invested £250K in Equinox. The technology developed by the company takes a logic- enhanced properties and are able to be the subject of novel Equinox customers include major pharmaceutical based approach to discover novel drugs, using computers to ‘composition of matter’ patents,” says Muggleton. companies such as Japanese pharmaceutical company learn from a set of biologically-active molecules. It combines Astellas and agro chemical companies such as knowledge about traditional drug discovery methods and Proving the technology Syngenta, as well as SMEs based in the UK, Europe, computer-based analyses, and focuses on the key stages in A three-year BBSRC grant in 2003 funded the work of Japan and the USA.
    [Show full text]
  • Virtual Screening of Human Class-A Gpcrs Using Ligand Profiles Built on Multiple Ligand-Receptor Interactions
    Article Virtual Screening of Human Class-A GPCRs Using Ligand Profiles Built on Multiple Ligand–Receptor Interactions Wallace K.B. Chan 1,2 and Yang Zhang 1,3 1 - Department of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109, USA 2 - Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA 3 - Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA Correspondence to Yang Zhang: Department of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218, USA. [email protected] https://doi.org/10.1016/j.jmb.2020.07.003 Edited by Michael Sternberg Abstract G protein-coupled receptors (GPCRs) are a large family of integral membrane proteins responsible for cellular signal transductions. Identification of therapeutic compounds to regulate physiological processes is an important first step of drug discovery. We proposed MAGELLAN, a novel hierarchical virtual-screening (VS) pipeline, which starts with low-resolution protein structure prediction and structure-based binding-site identification, followed by homologous GPCR detections through structure and orthosteric binding-site comparisons. Ligand profiles constructed from the homologous ligand–GPCR complexes are then used to thread through compound databases for VS. The pipeline was first tested in a large-scale retrospective screening experiment against 224 human Class A GPCRs, where MAGELLAN achieved a median enrichment factor (EF) of 14.38, significantly higher than that using individual ligand profiles. Next, MAGELLAN was examined on 5 and 20 GPCRs from two public VS databases (DUD-E and GPCR-Bench) and resulted in an average EF of 9.75 and 13.70, respectively, which compare favorably with other state-of- the-art docking- and ligand-based methods, including AutoDock Vina (with EF = 1.48/3.16 in DUD-E and GPCR-Bench), DOCK 6 (2.12/3.47 in DUD-E and GPCR-Bench), PoLi (2.2 in DUD-E), and FINDSITEC- comb2.0 (2.90 in DUD-E).
    [Show full text]
  • A Composite Approach to Protein Structure Evolution
    COMPARATIVE QUANTITATIVE GENETICS OF PROTEIN STRUCTURES: A COMPOSITE APPROACH TO PROTEIN STRUCTURE EVOLUTION by Jose Sergio Hleap Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Dalhousie University Halifax, Nova Scotia December 2015 c Copyright by Jose Sergio Hleap, 2015 To my parents for all the support and the drive they instilled on me To my girlfriend for all the love and support during this process To my supervisor for the guidance provided And last but not least, To whomever had the patience to read this document ii Table of Contents Abstract ...................................... vi List of Abbreviations Used .......................... vii Acknowledgements ............................... x Chapter 1 Introduction .......................... 1 Chapter 2 Morphometrics of protein structures: Geometric mor- phometric approach to protein structure evaluation .. 4 2.1GMmethodsinproteinstructures.................... 8 2.1.1 Abstractingaproteinstructureasashape........... 8 2.1.2 GPSvsProteinstructurealignment............... 9 2.1.3 FormDifferenceinproteinstructures.............. 14 2.2 Applicability of GM-like methods .................... 20 2.2.1 Statistical analysis of the α-Amylase evolutionary variation . 21 2.2.2 StatisticalanalysisoftheNPC1proteinsimulation...... 29 Chapter 3 Defining structural and evolutionary modules in pro- teins: A community detection approach to explore sub- domain architecture ...................... 34 3.1 Landmark definition ........................... 37 3.2 Contact
    [Show full text]
  • Drosophila Melanogaster
    ORTHOLOGOUS PAIR TRANSFER AND HYBRID BAYES METHODS TO PREDICT THE PROTEIN-PROTEIN INTERACTION NETWORK OF THE ANOPHELES GAMBIAE MOSQUITOES By Qiuxiang Li SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY AT IMPERIAL COLLEGE LONDON SOUTH KENSINGTON, LONDON SW7 2AZ 2008 °c Copyright by Qiuxiang Li, 2008 IMPERIAL COLLEGE LONDON DIVISION OF CELL & MOLECULAR BIOLOGY The undersigned hereby certify that they have read and recommend to the Faculty of Natural Sciences for acceptance a thesis entitled \Orthologous pair transfer and hybrid Bayes methods to predict the protein-protein interaction network of the Anopheles gambiae mosquitoes" by Qiuxiang Li in partial ful¯llment of the requirements for the degree of Doctor of Philosophy. Dated: 2008 Research Supervisors: Professor Andrea Crisanti Professor Stephen H. Muggleton Examining Committee: Dr. Michael Tristem Dr. Tania Dottorini ii IMPERIAL COLLEGE LONDON Date: 2008 Author: Qiuxiang Li Title: Orthologous pair transfer and hybrid Bayes methods to predict the protein-protein interaction network of the Anopheles gambiae mosquitoes Division: Cell & Molecular Biology Degree: Ph.D. Convocation: March Year: 2008 Permission is herewith granted to Imperial College London to circulate and to have copied for non-commercial purposes, at its discretion, the above title upon the request of individuals or institutions. Signature of Author THE AUTHOR RESERVES OTHER PUBLICATION RIGHTS, AND NEITHER THE THESIS NOR EXTENSIVE EXTRACTS FROM IT MAY BE PRINTED OR OTHERWISE REPRODUCED WITHOUT THE AUTHOR'S WRITTEN PERMISSION. THE AUTHOR ATTESTS THAT PERMISSION HAS BEEN OBTAINED FOR THE USE OF ANY COPYRIGHTED MATERIAL APPEARING IN THIS THESIS (OTHER THAN BRIEF EXCERPTS REQUIRING ONLY PROPER ACKNOWLEDGEMENT IN SCHOLARLY WRITING) AND THAT ALL SUCH USE IS CLEARLY ACKNOWLEDGED.
    [Show full text]
  • Erepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs
    Databases/ Web Servers eRepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs Michal Brylinski 1,2, Misagh Naderi 1, Rajiv Gandhi Govindaraj 1 and Jeffrey Lemoine 1,3 1 - Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA 2 - Center for Computation & Technology, Louisiana State University, Baton Rouge, LA 70803, USA 3 - Division of Computer Science and Engineering, Louisiana State University, Baton Rouge, LA 70803, USA Correspondence to Michal Brylinski: Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. [email protected] https://doi.org/10.1016/j.jmb.2017.12.001 Edited by Michael Sternberg Abstract About 7000 rare, or orphan, diseases affect more than 350 million people worldwide. Although these conditions collectively pose significant health care problems, drug companies seldom develop drugs for orphan diseases due to extremely limited individual markets. Consequently, developing new treatments for often life-threatening orphan diseases is primarily contingent on financial incentives from governments, special research grants, and private philanthropy. Computer-aided drug repositioning is a cheaper and faster alternative to traditional drug discovery offering a promising venue for orphan drug research. Here, we present eRepo-ORP, a comprehensive resource constructed by a large-scale repositioning of existing drugs to orphan diseases with a collection of structural bioinformatics tools, including eThread, eFindSite, and eMatchSite. Specifically, a systematic exploration of 320,856 possible links between known drugs in DrugBank and orphan proteins obtained from Orphanet reveals as many as 18,145 candidates for repurposing. In order to illustrate how potential therapeutics for rare diseases can be identified with eRepo-ORP, we discuss the repositioning of a kinase inhibitor for Ras-associated autoimmune leukoproliferative disease.
    [Show full text]
  • Annual Review 2003
    The Wellcome Trust is an independent – 30 September 2003 1 October 2002 Review Annual Trust Wellcome The research-funding charity, established under the will of Sir Henry Wellcome in 1936. Annual It is funded from a private endowment, which is managed with long-term stability and growth in mind. Review Its mission is to foster and promote research with the aim of improving human and animal health. Its work covers four areas: 2003 Knowledge – improving our understanding of human and animal biology in health and disease, and of the past and present role of medicine in society. Resources – providing exceptional researchers with the infrastructural and career support they need to fulfil their potential. Translation – ensuring maximum health benefits are gained from biomedical research. Public engagement – raising awareness of the medical, ethical and social implications of biomedical science. www.wellcome.ac.uk Annual Review 2003 Contents 2 From the Director 6 Making a difference 8 Financial summary 10 Knowledge 16 Resources Advancing knowledge and Contributing to a long-term and understanding in the biomedical vibrant research environment. sciences and their impact on society – past, present and future. 22 Translation 28 Public engagement Advancing the translation of Trust- Engaging with the public through funded research into health benefits. informed dialogue. The cover images are of objects displayed at the ‘Medicine Man’ exhibition at the British Museum in 2003.The exhibition commemorated the 150th anniversary of the birth of Henry Wellcome. Front cover Back cover, left Back cover, right Yoruban figures representing Protective amulet said to Tobacco resuscitator kit. 34 A year at the Trust deceased twins, 1870–1910.
    [Show full text]
  • ELIXIR UK Node
    ELIXIR‐UK the UK Node of the European Life Sciences Infrastructure for Biological Information www.elixir‐europe.org elixir‐uk.org The USA 2 EUROPE 3 UK: Poor data quality hindering government open data programme • “A Computer Weekly analysis of 50 spending data releases by the Cabinet Office since May 2010 has shown they were so marred by "dirty data" and inconsistent computer encoding, systematic scrutiny would require advanced computer programming skills.” Thursday 28 August 2014 http://www.computerweekly.com/news/2240227682/Poor‐data‐quality‐ hindering‐government‐open‐data‐transparency‐programme 4 Establishing a fresh UK activity Oxford University Computational Genomics Analysis and Training (CGAT) €1.6million The University of Manchester Seed fund The Oxford e‐Research Centre European Bioinformatics Institute (EMBL‐EBI) in kind University of Cardiff & NERC EOS Centre funding The Genome Analysis Centre (TGAC) University College London University of Birmingham University of Edinburgh Queen Mary, London University of Cambridge University of Liverpool Centre for Genomic Medicine Harness existing expertise Core Staff TeSS Staff Train across the Spectrum Technical Life Science Infrastructure Researchers Service Providers TCRS TCIT Training Training Coordinator, Coordinator, Research Infrastructure Science Technology Lee Larcombe Aleks Pawlik ELIXIR‐UK working across Europe: Training Coordination Group Mission: to establish an interacting ELIXIR wide training community & to ensure coherency in the delivery of training related to ELIXIR activities. TrCG members: Chair: Rita Hendricusdottir BE Katrijn Vannerum CZ Daniel Svozil DK Peter Longreen EE Hedi Peterson FI Eija Korpelainen FR Julie Thompson IL Michal Linial IT Allegra Via NL Celia van Gelder NO Ståle Nygård PT Pedro Fernandes SI Brane L.
    [Show full text]